Export

Paromomycin
Essential medicine status
General description
Paromomycin is an antimicrobial medicine used in the treatment of leishmaniasis and some parasitic infections.
INN
Paromomycin
Medicine type
Chemical agent
EML status history
First added in 1977 (TRS 615) for Amoebiasis
Removed in 1982 (TRS 685) for Amoebiasis
Added in 2007 (TRS 946) for Visceral leishmaniasis
Therapeutic equivalent for
Wikipedia
DrugBank
Recommendations
Section
Antileishmaniasis medicines
  • Parenteral > General injections > IM: 750 mg paromomycin base (as sulfate)
Section
Antiamoebic and antigiardiasis medicines
  • Oral > Liquid: 125 mg per 5 mL as sulfate
  • Oral > Solid: 250 mg as sulfate
Indications